CTSO (CytoSorbents) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CTSO CytoSorbents Corp CTSO
31 GF Score
Price $0.40
GF Value $0.86
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is CytoSorbents Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

CTSO vs GTHP, LFWD, PETV: Short Interest Comparison

For the Medical Devices subindustry, CytoSorbents's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CytoSorbents Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CytoSorbents's Short Interest distribution charts can be found below:

* The bar in red indicates where CytoSorbents's Short Interest falls into.


CTSO
31GF Score
CytoSorbents Corp CTSO
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CytoSorbents (CTSO) Overvalued in 2026?

Based on GuruFocus' analysis, CytoSorbents stock appears to be undervalued. The current stock price of $0.40 is trading 53.5% below its estimated GF Value™ of $0.86. GuruFocus considers CytoSorbents to be Possible Value Trap.

Key valuation signals for CTSO:

  • Short Interest:
  • GF Value™: $0.86 vs. price of $0.40 (53.5% below fair value)
  • GF Score™: 31/100 with 5 warning signs

No single metric tells the full story. See the CTSO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CytoSorbents Business Description

Other Exchanges HQE1:Germany
Address 305 College Road East, Princeton, NJ, USA, 08540
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
31GF Score

Get the complete analysis for CTSO

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40
Price
$0.86
GF Value